Delivery Order HHSN271201600005I-75N95024F00002
Award Date
7/15/24
Potential Completion Date
6/30/26
Potential Value
$3.4M
Federal Agency
National Institute on Drug Abuse
Awardee
PPD Development LP
Ultimate Awardee
Not listed
NAICS Category
541712 - Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Cape Fear, NC 28401, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,265,588.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS), to PPD Development LP, a global contract research organization. The contract is for a first-in-human randomized, double-blind, placebo-controlled single ascending dose (SAD) Phase I study on the development of neurotherapeutics. The contract is not set aside and is...
This is a firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract, valued at $696,693.16, was awarded to PPD Development LP, a global contract research organization (CRO), to provide PPD development site and study monitoring services. The contract has no set-aside designation and is part of several indefinite delivery...
This federal contract award is for regulatory consulting assistance and research and development for clinical studies in the Blueprint MedTech program, which is managed by the National Institute on Drug Abuse (NIDA), a civilian agency. The award was made to PPD Development LP, a global contract research organization (CRO) and subsidiary of Thermo Fisher Scientific. The contract has a period of performance from September 15, 2023 to September 14, 2024, with a ceiling value of $64,107.00. This...
This is a $1,737,262.53 task order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke to PPD Development LP, a global contract research organization (CRO). The task order is for Phase I clinical trials in the development of neurotherapeutics and is part of the larger "Phase I Clinical Trials for Development of Neurotherapeutics" indefinite delivery/indefinite quantity (ID/IQ) contract....
This is a cost-plus-fixed-fee Delivery Order awarded by the National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke to PPD Development LP, a global contract research organization (CRO). The $2,104,350.00 task order is for protocol development, database build, and bioanalytical methods development in support of a Phase I clinical trial for the neurotherapeutic drug candidate AZD4041. The award is part of a larger Indefinite Delivery/Indefinite Quantity...
This is a Cost Plus Fixed Fee definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to PPD Development LP, a global contract research organization (CRO). The contract, valued at $66,339,562.95, is for the TAS::75 0885::TAS NIAID DAIT CLINICAL SITE MONITORING CENTER and has a performance period ending on February 23, 2023. PPD Development LP, a subsidiary of Thermo Fisher...
This contract award to PPD Development LP by the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), is for Phase I clinical trials in the development of neurotherapeutics. The $433,977 firm-fixed-price delivery order is part of a larger indefinite delivery/indefinite quantity (ID/IQ) contract for this program area. The contract supports administrative and overall clinical operations, with a period of performance through June 30,...
This is a cost-plus-fixed-fee definitive contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to PPD Development LP, a global contract research organization (CRO), for R&D services related to biomedical basic research. The $27,437,431.92 contract has a performance period ending on October 31, 2021 and is not set aside for any specific business type. PPD Development LP has been awarded over $500 million in prime federal...
This is a $5,758,524.34 delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to PPD Development LP, a global contract research organization (CRO). The contract is to provide monitoring services for a Phase III clinical trial, specifically trial A5300B/PHOENIX. It is a cost-plus-fixed-fee contract with an ultimate completion date of December 14, 2025. The contract was awarded on April 15, 2019 and is not...
This is a Cost Plus Fixed Fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to PPD Development LP for NIAID Clinical Site Monitoring services. The contract has a ceiling value of $140,719,763.00 and a period of performance ending on January 31, 2024. PPD Development LP is a global contract research organization (CRO) that provides clinical trial and research support services to federal...